Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common chronic childhood disorders, and its prevalence is on the rise. National survey data from 2016 indicate that 9.4 percent of children in the United States ages 2 to 17 have had an ADHD diagnosis, including 2.4 percent of children 2 to 5 years of age. In that national survey, 8.4 percent of children ages 2 to 17 currently had ADHD, representing 5.4 million children. Among children and adolescents with current ADHD, almost two-thirds were taking medication, and approximately half had received behavioral treatment for ADHD in the past year. Nearly one quarter had received neither type of treatment of ADHD.

Symptoms of ADHD occur in childhood, and most children with ADHD will continue to have symptoms and impairment through adolescence and into adulthood. Children with ADHD may have difficulty controlling their behavior in school and social settings and often fail to achieve their full academic potential. Additionally, ADHD is frequently present with other psychiatric disorders.

De sleutel tot effectieve langetermijnbehandeling van het kind met ADHD is continuïteit van de zorg met clinici die ervaring hebben met de behandeling van ADHD. De frequentie en duur van follow-upsessies moeten voor elk gezin en elk kind worden geïndividualiseerd, afhankelijk van de ernst van de ADHD-symptomen; de mate van comorbiditeit van andere psychiatrische aandoeningen; de reactie op de behandeling; en de mate van beperking bij thuis-, school-, werk- of leeftijdsgerelateerde activiteiten.

Richtlijnen voor diagnose en behandeling

Healthcare Effectiveness Data and Information Set (HEDIS®)1 Tip Sheets

Ledenmaterialen

Screening Tools

1 HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA).